FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of formula
which exhibits activity against protein kinases, as well as to methods of its preparation and pharmaceutical compositions.
EFFECT: increased compound activity.
15 cl, 8 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2565071C2 |
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR USE OF SAID COMPOUNDS AND METHODS | 2008 |
|
RU2487121C2 |
PYRROLO[2,3-B]PYRIDINE DERIVATIVE AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2418800C2 |
COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USE THEREOF | 2007 |
|
RU2452738C2 |
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
KINASES MODULATION AND INDICATIONS FOR ITS USE | 2012 |
|
RU2631487C2 |
INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES | 2014 |
|
RU2666532C2 |
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH | 2019 |
|
RU2788000C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
Authors
Dates
2017-09-05—Published
2012-11-28—Filed